Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0

IRVINE, California - Relsys International today announced the release of the Argus Safety
Suite 5.0, the new standard in global Drug Safety & Risk Management systems.
The Argus Safety Suite 5.0 is a full stack release.

Argus Safety 5.0 features important productivity and usability
enhancements to the most widely used adverse events management system in the
world. It also features ongoing performance enhancements to the highly stable
and efficient Argus database, ensuring that pharma companies can rapidly
process and manage all of their reporting obligations.

Argus Perceptive 5.0 is a leading risk management system, pioneering the
Structured Signal Management (SSM) approach. Argus Perceptive 5.0 enables
powerful risk assessments with greater data accuracy, ensuring that medical
reviewers get advanced notice of signals and potentially leading to earlier
risk identification. While adhering to the Structured Signal Management
approach, pharma companies ensure that their surveillance teams follow the
signal and risk management process according to company-defined SOPs within
an integrated environment.

Bruce Palsulich, Chief Innovation & Strategy Officer at Relsys,
commented, “Increasing regulatory scrutiny and greater physician/consumer
awareness have led directly to a record number of adverse events reported to
regulators. In fact, in the first quarter of 2008, the FDA received a record
number of adverse event reports, 82% of which originated from manufacturers.
Pharma companies are struggling to meet this burden and are increasingly
looking to commercial drug safety databases to help manage their regulatory
requirements. I believe this is exactly why more than 1 out of every 3 of the
Top 100 pharma have selected Argus Safety from Relsys to manage their
pharmacovigilance obligations.” Palsulich continued, “Furthermore, pharma is
learning that signal detection tools by themselves do not solve their
problems. Many companies now realize that Structured Signal Management
provides a framework to transform large amounts of data into useful and
actionable information. This is how Argus Perceptive adds true value to the
science of signal detection.”

Parties interested in learning more about the Argus Safety(TM) Suite 5.0
may visit the Relsys at the DIA EuroMeeting (booth #1240) in Berlin, Germany
or may request a copy of the Structured Signal Management white paper via
email at info@relsys.net.

About Relsys International

Relsys International provides the industry-leading Argus Safety Suite, a
complete solution for pharmacovigilance and risk management that helps
pharmaceutical, biotech and medical device companies improve product safety
and ensure ongoing compliance with global regulations. The company, founded
in 1987, works in partnership with its customers to develop and deliver
innovative solutions to long-term business needs, and to provide critical
components to support its clients’ corporate risk management strategies.
Argus Safety(TM), the company’s flagship product, is the world’s best selling
adverse event reporting software, and is used by more of the leading
pharmaceutical companies than any other solution. Relsys is a privately held
company, headquartered in Irvine, California. For more information, visit
www.relsys.net, or call +1-949-453-1715.

Source: Relsys International

Abdul Rastagar of Relsys International, +1-949-453-1715